Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Dendreon Corp

DNDN:US

Ticker Change

Company Profile for Dendreon Corp (DNDN)

Dendreon Corporation discovers and develops immunologically based therapeutic products for the treatment of cancer. The Company combines knowledge in immunology and antigen engineering with proprietary cell separation technologies to develop therapeutic vaccines that induce cell-mediated immunity, the body's key defense against cancer.

Contact Information

Dendreon Corp

1301 2nd Avenue
Seattle, WA 98101
United States
Phone: 1-206-256-4545
Fax: 1-206-256-0571

Key Executives for Dendreon Corp (DNDN)

Douglas G Watson "Doug"ChairmanGregory R CoxCFO/Treasurer
Andrew S SandlerExec VP/Chief Medical OfficerLindsay RoccoExec VP:Corporate Communications
William MonteithExec VP:Technical OperationsBill JenkinsonVP/Chief Marketing Officer
Silvio PachecoVP/Chief Customer OfficerKaren E BrophyVP/Head:Human Resources

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil